The Division of Infectious Diseases (ID) in the Department of Medicine at MCG at Augusta University is involved in a full range of care for patients, engaging in the discovery of new treatments, and finding innovative cures for infectious diseases.
The faculty and staff in the Infectious Diseases division are dedicated to advancing the study and practice of the field of Infectious Diseases by:
Providing excellent, comprehensive, patient-centered medical care
Preparing the next generation of Infectious Diseases physicians for evidence-based practice in a variety of settings
Contributing to the development of medical knowledge via recruitment and participation in cutting-edge research trials
Infectious Diseases Office
Annabelle Shepherd
706-721-1244
706-721-4517
1120 15th Street
AE 3033
Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to
Pulmonary Microvascular Endothelial Permeability
Microbiology Spectrum
Septic arthritis in the end-stage renal disease population
Journal of Investigative Medicine
Mathematical modeling of impact of eCD4-Ig molecule in control and management of HIV
within a host
Mathematical Biosciences and Engineering
Guido Verbeck, PhD, the new chair of the Department of Chemistry and Biochemistry in the College of Science and Mathematics, has been awarded a grant from the Bill & Melinda Gates Foundation for his research on improving disease detection.
Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators found that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not.
The bacterium is seen in more than 140 million cases worldwide and causes more than 30,000 deaths each year.
“Kidney transplant patients are at risk for all kinds of infections,” says Dr. Sandeep Padala, nephrologist at MCG and the Augusta University Health System.
